Aortic Atherosclerosis in Systemic Lupus Erythematosus - Wikidata - awgldk - TriplyDB

Aortic Atherosclerosis in Systemic Lupus Erythematosus

Aortic Atherosclerosis in Systemic Lupus Erythematosus

http://www.wikidata.org/entity/Q34938841

about

Management of Cardiovascular Risk in Patients with Chronic Inflammatory Diseases: Current Evidence and Future Perspectives.Novel Insights in Systemic Lupus Erythematosus and Atherosclerosis.

P2860

Q38972344-E2D18A25-574F-4F23-89F6-37481644069E Q50052184-AA9E9EFD-1237-4C54-8AFA-43F4B6F93CF1

P2860

Aortic Atherosclerosis in Systemic Lupus Erythematosus

http://www.wikidata.org/entity/Q34938841

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

name

Aortic Atherosclerosis in Systemic Lupus Erythematosus

@ast

Aortic Atherosclerosis in Systemic Lupus Erythematosus

@en

Aortic Atherosclerosis in Systemic Lupus Erythematosus

@nl

type

label

Aortic Atherosclerosis in Systemic Lupus Erythematosus

@ast

Aortic Atherosclerosis in Systemic Lupus Erythematosus

@en

Aortic Atherosclerosis in Systemic Lupus Erythematosus

@nl

prefLabel

Aortic Atherosclerosis in Systemic Lupus Erythematosus

@ast

Aortic Atherosclerosis in Systemic Lupus Erythematosus

@en

Aortic Atherosclerosis in Systemic Lupus Erythematosus

@nl

P1433

Q34938841-4AF8CE7D-4018-4EFD-83CF-5B9C6031CAA0

P1476

Q34938841-337B258B-F372-4F1D-A522-764ED45B86F1

P2093

Q34938841-29A641AD-72AC-4DCF-BA96-DDDB871B1454

Q34938841-3C5516B9-4E19-4E8D-84AE-E04472FE8271

Q34938841-4422F345-A068-4FFB-B698-D7107A83F221

Q34938841-67654481-5A83-4327-AC03-9B036D5137AD

Q34938841-777069F2-3C2A-4504-B8A4-43672D9BB77C

Q34938841-D2E67B82-9B34-4CF4-9E7E-00E4533EACC6

P2860

Q34938841-00946F8B-E810-4987-BF3B-A31E177E236A

Q34938841-00E148D5-B942-4E0E-8298-AA7A3A8A1684

Q34938841-03CF7936-8BC7-4624-BB1D-9EAE063FB029

Q34938841-0A14A138-248B-4197-A50B-D6D55C1123ED

Q34938841-0C5824F0-E1AE-4D7A-A038-4B4C070336EB

Q34938841-112C63EB-5F5D-434F-B315-261534229538

Q34938841-12E1A814-D430-4497-ABD2-584C5A51FAB8

Q34938841-1573307D-A477-4260-A0E9-63C83A3B78A7

Q34938841-2563A84E-CDEF-4732-8511-5A1D0B547DC3

Q34938841-28681518-480D-40CF-85E7-998B55663C6C

P31

Q34938841-512DFD55-F110-46F9-BB82-1366BBBC1628

P356

Q34938841-ECDE4F16-ECE6-4FD2-AE81-9E87CF773182

P478

Q34938841-67107359-58AE-469A-A8FB-E5BFAF2F219F

P50

Q34938841-FBD57B45-94D1-485B-ADDB-C08BDD78C42A

P577

Q34938841-B8E63913-7A07-4403-BF3A-7B74DCE426E9

P698

Q34938841-2F886143-1A87-4AAD-87BB-A9B82BCBE01C

P921

Q34938841-437785A2-CA36-4E61-9BA0-78458733D850

Q34938841-D5535206-9773-4DD3-8F98-4F2E92261496

P932

Q34938841-79D6A21A-D0E4-482A-BBD4-01919E2FE160

P356

2161-1149.S5-006

P1433

Rheumatology (Sunnyvale, Calif.)

P1476

Aortic Atherosclerosis in Systemic Lupus Erythematosus

@en

P2093

Carlos A Roldan

http://www.w3.org/2001/XMLSchema#string

Leonardo Macias

http://www.w3.org/2001/XMLSchema#string

Michelle Ratliff

http://www.w3.org/2001/XMLSchema#string

Paola C Roldan

http://www.w3.org/2001/XMLSchema#string

Richard Snider

http://www.w3.org/2001/XMLSchema#string

Rodrigo Rodriguez

http://www.w3.org/2001/XMLSchema#string

P2860

Atherosclerosis of the descending aorta predicts cardiovascular events: a transesophageal echocardiography study

Atherosclerosis — An Inflammatory Disease

The effect of mycophenolate mofetil on disease development in the gld.apoE (-/-) mouse model of accelerated atherosclerosis and systemic lupus erythematosus

Libman-Sacks endocarditis and embolic cerebrovascular disease.

EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics.

Prediction of short term mortality in systemic lupus erythematosus with time dependent measures of disease activity.

Risk factors in the progression of subclinical atherosclerosis in women with systemic lupus erythematosus.

Detection of coronary artery disease and the role of traditional risk factors in the Hopkins Lupus Cohort.

Prophylactic antithrombotic therapy for patients with systemic lupus erythematosus with or without antiphospholipid antibodies: do the benefits outweigh the risks? A decision analysis.

Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus.

P31

scholarly article

P356

10.4172/2161-1149.S5-006

http://www.w3.org/2001/XMLSchema#string

P478

Suppl 5

http://www.w3.org/2001/XMLSchema#string

P50

Wilmer L Sibbitt

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25593786

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

4292892

http://www.w3.org/2001/XMLSchema#string